Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 9Neoplasms 7Agnosia 5Multiple Myeloma 4Hodgkin Disease 4Pain, Postoperative 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Cancer Pain 3Breast Neoplasms 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Carcinoma in Situ 2Burkitt Lymphoma 2Acute Pain 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1

Interventions

Lidocaine 1Imiquimod 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Paget Disease, Extramammary × Acetaminophen × Clear all
NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡